dual DNA gyrase/DNA topoisomerase IV inhibitor (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedual DNA gyrase/DNA topoisomerase IV inhibitor (Pfizer)
Drug Alias NameATPase/DNA gyrase/DNA topoisomerase IV inhibitor (Pfizer)dual gyrB/parE inhibitors (Pfizer)PD-0326448PD-0305970
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitorsBacterial nucleic acid synthesis inhibitors
TargetsBacterial DNA gyraseTopoisomerase IV
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A